NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 152.610
- +1.080+0.71%
Close Feb 26 16:00 ET
- 152.610
- 0.0000.00%
Pre 04:50 ET
9.13BMarket Cap-22.29P/E (TTM)
155.990High148.180Low527.16KVolume151.560Open151.530Pre Close80.22MTurnover0.89%Turnover RatioLossP/E (Static)59.84MShares157.37052wk High-82.40P/B9.06BFloat Cap111.09052wk Low--Dividend TTM59.37MShs Float183.980Historical High--Div YieldTTM5.15%Amplitude11.920Historical Low152.170Avg Price1Lot Size
About Ascendis Pharma A/S Company
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
Company Profile
SymbolASND
Company NameAscendis Pharma A/S
Listing DateJan 28, 2015
Issue Price18.00
Founded2006
CEOMr. Jan Moller Mikkelsen
MarketNASDAQ
Employees1017
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressTuborg Boulevard 12
CityHellerup
ProvinceCapital Region
CountryDenmark
Zip Code2900
Phone45-70-22-22-44
Company Executives
- Name
- Position
- Salary
- Jan Moller Mikkelsen
- President, Chief Executive Officer and Director
- --
- Michael Wolff Jensen
- Executive Vice President and Chief Legal Officer
- --
- Scott T Smith
- Executive Vice President and Chief Financial Officer
- --
- Lotte Sonderbjerg
- Executive Vice President and Chief Administrative Officer
- --
- Aimee Shu
- Executive Vice President and Chief Medical Officer
- --
- Mads Bodenhoff
- Senior Vice President, Head of Finance and Principal Accounting Officer
- --
- Flemming Steen Jensen
- Executive Vice President, Product Supply and Quality
- --
- Dr. Kennett Sprogoe, PhD
- Executive Vice President and Head of Innovation and Research
- --
- Jay Donovan Wu
- Executive Vice President and U.S. President
- --
- Dr. Stina Singel, M.D.
- Executive Vice President and Head of Clinical Development, Oncology
- --
- Dr. Albert Cha, M.D.,PhD
- Chairman of the Board
- --
- Lisa Bright
- Independent Director
- --
- Siham Imani
- Independent Director
- --
- William Carl Fairey, Jr
- Independent Director
- --
- Lars Holtug
- Independent Director
- --